Scientists discover a cause of lupus, possible way to reverse it (news.feinberg.northwestern.edu)

Article summary

Scientists from Northwestern University and Brigham and Women's Hospital have discovered a molecular defect that drives the immune response in lupus, a chronic autoimmune disease. The defect is related to the insufficient activation of the aryl hydrocarbon receptor (AHR) pathway, leading to an imbalance in immune cells. This discovery may lead to the development of new treatments for lupus. The researchers are working to find ways to deliver AHR-activating molecules to patients safely and effectively.

Main themes

• Lupus research
• Autoimmune diseases
• Immune cell imbalance
• New treatment development
• Aryl hydrocarbon receptor

What commenters say

• The discovery of the molecular defect in lupus may have implications for understanding and treating other autoimmune diseases, such as multiple sclerosis and psoriasis.
• Some commenters believe that the focus on lupus research may lead to breakthroughs in understanding and treating other diseases, including ME/CFS.
• There is a need for more research into the underlying mechanisms of autoimmune diseases, rather than just treating the symptoms.
• The use of AHR activators, such as tapinarof, may be effective in treating autoimmune diseases, but more research is needed to understand their mechanisms and potential side effects.
• Some commenters are skeptical about the potential of new treatments for autoimmune diseases, citing the complexity of the immune system and the need for more targeted approaches.
• The role of the microbiome in autoimmune diseases is often overlooked and deserves more research attention.
• There is a need for more funding and research into ME/CFS, which is often neglected in favor of other diseases.
• The relationship between autoimmune diseases and mental health complications, such as depression, is an area that requires further study.